Literature DB >> 9174290

Cognitive dysfunction after ventricular fibrillation during implantable cardiovertor/defibrillator procedures is related to duration of the reperfusion interval.

J M Murkin1, D L Baird, J S Martzke, R Yee.   

Abstract

The insertion of implantable cardioverter/defibrillators (ICD) requires induction of repeated episodes of ventricular fibrillation (VF). The neuropsychological repercussions associated with repeated inducement of hypotension and cerebral ischemia are unknown. In this prospective clinical trial, 1 day prior to ICD assessment/implantation and 5 days postprocedure, 14 patients underwent neurological and cognitive screening. Cognitive dysfunction was defined as impaired performance in one of four cognitive domains. Neurological impairment was defined as a decrement of 2 or more points from baseline of a total possible score of 45 points. Intraoperative hemodynamics, including the reperfusion interval (RI; end of preceding fibrillation to beginning of the next), were recorded. Patients underwent an average of 12 +/- 6 episodes of VF with average duration of mean arterial pressure (MAP) <50 mm Hg for 17 +/- 9 s (range 6-39 s) and of MAP <30 mm Hg for 11 +/- 5 s (range 2-22 s). Nine patients, in none of whom the predetermined criteria for neurologic impairment was met, demonstrated a new subtle neurologic finding postoperatively. Ten of 14 patients met the criterion for cognitive dysfunction 5 days postoperatively. The mean RI between episodes of VF was significantly different between those patients demonstrating cognitive dysfunction and the unimpaired patients (3.1 +/- 0.5 min in the group with cognitive dysfunction vs 3.9 +/- 0.8 min in the unimpaired group, P = 0.027). Five patients without cognitive impairment had longer RI between episodes of circulatory arrest than those showing impaired cognition. We conclude that cognitive dysfunction can occur after insertion of ICD and is related to the duration of RI.

Entities:  

Mesh:

Year:  1997        PMID: 9174290     DOI: 10.1097/00000539-199706000-00003

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

Review 1.  [Implantation of cardioverter-defibrillators. How much anesthesia is necessary?].

Authors:  T Sellmann; M Winterhalter; U Herold; P Kienbaum
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

2.  [Is the determination of the defibrillation threshold in patients with an implantable cardioverter-defibrillator still required?].

Authors:  M Licka; L Jahn; K Kelemen; F Voss; K Trappe; R Becker; O Bikou; M Hauck; M Koch; H A Katus; A Bauer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-11-13

3.  Exercise Interventions in Patients With Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Daniel A Steinhaus; Steven A Lubitz; Peter A Noseworthy; Daniel B Kramer
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-09       Impact factor: 2.081

4.  Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator.

Authors:  G Christ; R Becker; F Voss; K Kelemen; J Senges-Becker; M Hauck; W Schoels; I Bald; H A Katus; A Bauer
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

Review 5.  Cerebral near-infrared spectroscopy in the care of patients during cardiological procedures: a summary of the clinical evidence.

Authors:  Annelies Moerman; Frederik Meert; Stefan De Hert
Journal:  J Clin Monit Comput       Date:  2015-10-08       Impact factor: 2.502

6.  [Cerebral hemodynamics during implantation of cardioverter-defibrillator systems].

Authors:  T J Doering; H J Trappe; B Panning; H G Fieguth; B Steuernagel; B Schneider; S Piepenbrock; G C Fischer
Journal:  Med Klin (Munich)       Date:  1998-05-15

7.  Neurocognitive performance in hypertensive patients after spine surgery.

Authors:  Gene T Yocum; John G Gaudet; Lauren A Teverbaugh; Donald O Quest; Paul C McCormick; E Sander Connolly; Eric J Heyer
Journal:  Anesthesiology       Date:  2009-02       Impact factor: 7.892

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.